[
  {
    "date": "2023-12-30",
    "symbol": "AKAN",
    "period": "FY",
    "cash": 82816,
    "currentheldtomaturityinvestments": 11059,
    "tradeandothercurrentreceivables": 284513,
    "currentprepayments": 140583,
    "inventories": 1286894,
    "currentassets": 1805865,
    "propertyplantandequipment": 2519232,
    "intangibleassetsotherthangoodwill": 3799682,
    "noncurrentreceivables": 593232,
    "rightofuseassets": 121982,
    "noncurrentassets": 7034128,
    "assets": 8839993,
    "tradeandothercurrentpayables": 6014572,
    "currentleaseliabilities": 135337,
    "shorttermborrowings": 1366299,
    "currentholdbackpayable": 400000,
    "tradeandothercurrentpayablestorelatedparties": 2255522,
    "currentliabilities": 10171730,
    "longtermborrowings": 2497155,
    "noncurrentliabilities": 2497155,
    "liabilities": 12668885,
    "issuedcapital": 51020121,
    "otherreserves": 21053,
    "retainedearnings": -53363032,
    "accumulatedothercomprehensiveincome": -1507034,
    "equity": -3828892,
    "equityandliabilities": 8839993,
    "revenue": 2160052,
    "costofsales": 1908515,
    "grosslossprofitbeforelossonchangeinfairvaluebiologicalassets": 251537,
    "gainonchangeinfairvalueofbiologicalassets1": -140088,
    "grossprofit": 111449,
    "depreciationandamortisationexpense": 4283731,
    "professionalfeesexpense": 2978321,
    "employeebenefitsexpense": 2395583,
    "generalandadministrativeexpense": 505187,
    "operatingexpense": 10162822,
    "profitlossfromoperatingactivities": -10051373,
    "financeincome": 39,
    "financecosts": 255656,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": 148823,
    "adjustmentsofgainonsettlementondebt": 113037,
    "otherincome": 7055,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorlossmandatorilymeasuredatfairvalue": -264655,
    "lossondisposalofassets": -4495,
    "writeoffofapnet": -2697719,
    "impairmentloss": 24665564,
    "financeincomecost": -22223697,
    "profitlossfromcontinuingoperations": -32275070,
    "profitloss": -32275070,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -39412,
    "comprehensiveincome": -32314482,
    "basicearningslosspersharefromcontinuingoperations": -7.16,
    "basicearningslosspershare": -7.16,
    "weightedaverageshares": 4505263,
    "dilutedearningslosspersharefromcontinuingoperations": -7.16,
    "dilutedearningslosspershare": -7.16,
    "increasedecreasethroughfairvalueofvestedrestrictedstockunits": 774736,
    "cancellationoftreasuryshares": -200014,
    "issueofconvertibleinstruments": 314384,
    "increasedecreasethroughacquisitionofsubsidiary": 431149,
    "weightedaverageshareprice2019": 1.84,
    "adjustmentsfordepreciationandamortisationexpense": 4283731,
    "gainslossesonfairvalueadjustmentbiologicalassets": -140088,
    "adjustmentsfordecreaseincreaseinfinancialassetsheldfortrading": 264655,
    "adjustmentsforinterestexpense": 237319,
    "adjustmentsforfairvaluegainslosses": 839896,
    "adjustmentsforgainlossondisposalspropertyplantandequipment": -4495,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": -2697719,
    "adjustmentsforimpairmentlossreversalofimpairmentlossrecognisedinprofitorloss": 24665564,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 973382,
    "adjustmentsfordecreaseincreaseinprepaidexpenses": 64635,
    "adjustmentsfordecreaseincreaseininventories": 482716,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 1537397,
    "adjustmentsforincreasedecreaseinothercurrentliabilities": 91374,
    "cashflowsfromusedinoperatingactivities": -1500574,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 1502,
    "cashadvancesandloansmadetootherpartiesclassifiedasinvestingactivities": 84020,
    "proceedsfromsalesofpropertyplantandequipmentclassifiedasinvestingactivities": 110410,
    "cashflowsfromusedininvestingactivities": 24888,
    "proceedsfromadvancesfromrelatedparties": 1570145,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 742591,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 766169,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 60000,
    "cashflowsfromusedinfinancingactivities": 1486567,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 10881,
    "effectofexchangeratechangesoncashandcashequivalents": -172809,
    "cashandcashequivalents": 93875,
    "descriptionofaccountingpolicyfornewstandardsissuedandadoptedpolicytextblock": "(n)New standards issued and adopted",
    "descriptionofaccountingpolicyfornewstandardsissuedandoradoptedpolicytextblock": "(o)New standards issued, not yet adopted",
    "scheduleofusefullivesofpropertyandequipmenttabletextblock": "Depreciation is recognized in profitor loss over the estimated useful lives of each part of an item of property and equipment in a manner that most closely reflects management’sestimated future consumption of the future economic benefits embodied in the asset. The estimated useful lives for the current and comparativeperiods are as follows:",
    "scheduleofcarryingamountsofassetsandliabilitiesindiscontinuedoperationstabletextblock": "As at December 31, 2022, the carryingamounts of assets and liabilities of Bophelo Bio Science and Wellness (Pty) Ltd were as follows:",
    "disclosureoftradeandotherreceivablestabletextblock": "Trade and Other Receivables",
    "disclosureofreconciliationofmovementofentityinvestmenttabletextblock": "Set out below is a reconciliation ofthe movement of the Company’s investment during the years ended December 31, 2023 and 2022:",
    "disclosureofmovementinrightofuseassetstabletextblock": "The details of the right-of-use assetsrecognized as at December 31, 2023 are as follows:",
    "disclosureofloanreceivabletabletextblock": "December    31,      December    31,             2023      2022       Loan to Cellen Life Sciences Limited     $509,212      $483,588       Loan to an arm’s    length party      84,020       –             $593,232      $483,588",
    "disclosureofleaseliabilitytextblock": "Maturity      Incremental    borrowing rate      December                                            31,                                            2023      December                                            31,                                            2022       Current      2023       10.25%     $135,337      $214,058       Non-current      2024       10.25%      –       116,763                             $135,337      $330,821",
    "disclosureoftransactionswithkeymanagementpersonneexplanatory": "TheCompany has identified its Board of Directors, Executive Chairman, Chief Executive Officer (“CEO”), Chief Operating Officer(“COO”), Chief Financial Officer (“CFO”) and its President as its key management personnel who have the authorityand responsibility for planning, directing and controlling the Company’s main activities.",
    "disclosureofincometaxexpensetabletextblock": "Thecomponents of income tax expense (benefit) are as follows:",
    "disclosureofreconciliationofsegmentinformationtoentityinformationtabletextblock": "Setout below are reconciliations of each reportable segment’s revenues, profit or loss for the years ended December 31, 2023 and 2022,and assets and liabilities as at December 31, 2023 and 2022:",
    "countryofincorporationorresidenceofassociate": "Malta",
    "proportionofownershipinterestinsubsidiary": 1,
    "functionalcurrency": "EUR",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P10Y",
    "cashandcashequivalentsrecognisedasofacquisitiondate": 233407,
    "accountsreceivablerecognisedasofacquisitiondate": 605579,
    "biologicalassetsrecognizedasofacquisitiondate": 200457,
    "inventoryrecognisedasofacquisitiondate": 904006,
    "prepaymentsrecognizedasofacquisitiondate": 179597,
    "identifiableintangibleassetsrecognisedasofacquisitiondate": 24665772,
    "propertyplantandequipmentrecognisedasofacquisitiondate": 12936374,
    "tradeandotherpayablesrecognisedasofacquisitiondate": 3775599,
    "borrowingsrecognisedasofacquisitiondate": 4058030,
    "identifiableassetsacquiredliabilitiesassumed": 31891563,
    "otherrevenue": 1736369,
    "otheroperatingincomeexpense": -23026728,
    "gainsondisposalsofinvestments": 4495,
    "leaseliabilities": 135337,
    "borrowings": 135226,
    "tradereceivables": 155785,
    "currentreceivablesfromtaxesotherthanincometax": 39111,
    "otherreceivables": 89617,
    "adjustmentsforgainslossesonchangeinfairvaluelesscoststosellbiologicalassets": -822942,
    "increasedecreasethroughnetexchangedifferencesbiologicalassets": 13762,
    "increasedecreasethroughnetexchangedifferencesinvestmentproperty": 964,
    "propertyplantandequipmentcarryingamountatcostofrevaluedassets": 1355337,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 434344,
    "disposalsintangibleassetsotherthangoodwill": 93002,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": 35756,
    "propertyplantandequipmentcarryingamountaccumulateddepreciation": 2723166,
    "depreciationpropertyplantandequipment": 1541644,
    "accumulateddepreciationdisposal": -14771,
    "increasedecreasethroughforeignexchangemovementspropertyplantandequipment": 143044,
    "impairmentlossrecognisedinprofitorlosspropertyplantandequipment": 737994,
    "impairmentendingbalance": 737994,
    "amortisationintangibleassetsotherthangoodwill": 205424,
    "rightofuseassetsincreasedecreaseinrevaluationsurplus": 3336,
    "otherintangibleassets": 19554,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsotherthangoodwill": 1373,
    "loanreceivable": 509212,
    "currentmaturity": 2023,
    "currentincrementalborrowingrate": 0.1025,
    "noncurrentmaturity": 2024,
    "noncurrentincrementalborrowingrate": 0.1025,
    "interestpayableleaseliabilities": 25942,
    "othercashpaymentsfromoperatingactivities": 60000,
    "increasedecreaseinaccountspayableleaseliabilities": 180000,
    "increasedecreasethroughmovementinexchangeratesleaseliabilities": -18574,
    "undiscountedfinanceleasepaymentstobereceived": 140000,
    "numberofsharesoutstanding": 5628295,
    "issuedcapitalordinaryshares": 51020121,
    "increasedecreaseinsharesthroughissuanceuponconversionofnotes": 582193,
    "increasedecreaseinequitythroughissuanceofsharesuponconversionofnote": 314384,
    "increasedecreaseinsharesthroughissuanceofsharespursuanttothefirstoptionpaymenttoacquireacertainlandproperty": 879895,
    "issuanceofsharespursuanttothefirstoptionpaymenttoacquireacertainlandpropertynote9": 431149,
    "increasedecreaseinnumberofordinarysharesissued": 421052,
    "increasethroughissueofrestrictedshareunitsequity": 774736,
    "cancelledshares": -20620,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement": 1199052,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement": 723093,
    "weightedaverageexercisepriceofshareoptionsforfeitedandcancelledinsharebasedpaymentarrangement": 873524,
    "keymanagementpersonnelcompensation": 522669,
    "transactionswithkeymanagementpersonnel": 522669,
    "accountingprofit": -32275070,
    "applicabletaxrate": 0.265,
    "taxexpenseincomeatapplicabletaxrate": -8552894,
    "nondeductibleitems": 7671563,
    "nontaxableitems": -759559,
    "taxeffectofforeigntaxrates": 1630735,
    "taxeffectoftaxlosses": 10155,
    "financialassets": 93875,
    "financialassetsatfairvalue": 93875,
    "financialliabilities": 6014572,
    "financialliabilitiesatfairvalue": 6014572,
    "cashandcashequivalentsheldbyentityunavailableforusebygroup": 20087,
    "loansandreceivables": 84020,
    "tradeandotherpayablestorelatedparties": 2744510,
    "othercurrentpayables": 511238,
    "otherborrowings": 36771,
    "otherassets": 7421320,
    "otherliabilitie": 5949793,
    "revenuefromcontractswithcustomers": 1736369,
    "profitorlossforreportablesegments": -29566625,
    "profitlossbeforetax": -29566625,
    "eliminationofintersegmentassets": -19131000,
    "eliminationofintersegmentliabilities": -10214029,
    "otherliabilities": 5949792,
    "increasedecreaseinworkingcapital": 8365865,
    "accumulatedfairvaluehedgeadjustmentremaininginstatementoffinancialpositionforhedgeditemthatceasedtobeadjustedforhedginggainsandlossesassets": 53363032,
    "impairmentlossrecognisedinothercomprehensiveincome": 15937533,
    "profitlossofacquiree": 966426,
    "acquiredbusinesscontributed": 1736369,
    "gainlossthatrelatestoidentifiableassetsacquiredorliabilitiesassumedinbusinesscombination": 11271243,
    "tradeaccountsreceivablepercentage": 0.1,
    "balanceamountpercentage": 0.81,
    "inventoriestotal": 1286894,
    "numberofordinarysharespurchased": 4000000,
    "impairmentlossrecognisedinprofitorloss": 8728031,
    "numberofsharesissued": 582193,
    "amortizationrightofuseassets": 205424,
    "impairmentlossonfinancialassets": 15937533,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P1Y6M",
    "loanpayable": 500000,
    "notionalamount": 875016,
    "borrowingterm": "P30D",
    "borrowingsinterestrate": 0.03,
    "interestpayable": 3439527,
    "bearsinterestpercentage": 0.0075,
    "interestexpense": 14638,
    "interestincomeonimpairedfinancialassetsaccrued": 96475,
    "currentinterestpayable": 46811,
    "adjustedweightedaverageshares": 4505263,
    "maximumpercentageofissuedsharecapitalinqualifyingesopincentives": 0.2,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 1249986,
    "nominalorprincipalamountoffinancialinstrumentondiscontinuationofmeasurementatfairvaluethroughprofitorlossbecausecreditderivativeisusedtomanagecreditrisk": 1192953,
    "maturitydate": "2023-06-25",
    "aggregateprincipalamount": 1192953,
    "otherpayables": 1420963,
    "amountspayablerelatedpartytransactions": 2255522,
    "relatedpartykeymanagementremunerationpayable": 889367,
    "loanbalance": 49664,
    "accruals": 19306,
    "averageeffectivetaxrate": 0.1,
    "otherassetspercentagecontributedtofairvalueofplanassets": 0.05,
    "increasedecreaseinnetdefinedbenefitliabilityassetresultingfromexpenseincomeinprofitorloss": 17000,
    "percentageofconcentrationcreditriskrelatedtoaccountsreceivable": 0.81,
    "ifrsnumberofreportablesegments": 3,
    "agreementamount": 67392,
    "settlementagreement": 30000,
    "portionofconsiderationpaidreceivedconsistingofcashandcashequivalents": -2000000,
    "depositsfrombanks": 500000,
    "cashandcashequivalentspercentagecontributedtofairvalueofplanassets": 0.05,
    "aggregategrossproceeds": 446250,
    "entityregistrantname": "AKANDA CORP.",
    "tradingsymbol": "AKAN",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--12-31",
    "entitycommonstocksharesoutstanding": 5628295,
    "amendmentflag": "false",
    "entitycentralindexkey": 1888014,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-41324",
    "entityincorporationstatecountrycode": "Z4",
    "entityaddressaddressline1": "1a, 1b Learoyd Road",
    "entityaddresscityortown": "New Romney",
    "entityaddresspostalzipcode": "TN28 8XU",
    "entityaddresscountry": "GB",
    "contactpersonnelname": "Katie Field",
    "cityareacode": 1,
    "localphonenumber": "(202) 498 7917",
    "security12btitle": "Common Shares",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorname": "BF Borgers CPA PC",
    "auditorlocation": "Los Angeles, California",
    "auditorfirmid": 6580
  }
]